Dr. Jae Hyung Chang, MD

Dr. Chang practices at Columbia University Irving Medical Center in New York, New York.

Dr. Chang's NPI, 1831358167, was assigned on June 2, 2008. Dr. Chang graduated from Goethe Univ Frankfurt- Fac Med in 2001. Dr. Chang holds New York license 279365.

Dr. Chang's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Chang's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Chang is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Chang to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices. Vendor and product names are available with a free account.

Nephrology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chang is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chang's licenses on file in 4 states: New York, New Jersey, Connecticut and Massachusetts.

Dmand AI lists chronic kidney disease among the conditions Dr. Chang treats.

CMS data shows 991 Medicare services from Dr. Chang across 8 procedure codes in 2024, for 232 Medicare patients. Medicare paid $101,192 for them.

CMS counts 232 Medicare patients who saw Dr. Chang in 2024. The largest group is under 65, with 98 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 41% are also on Medicaid. Their average risk score is 5.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 61, with 40% women.

In 2024, Dr. Chang wrote 424 Medicare Part D claims for 84 patients. 92% of them were for generic drugs. CMS names the drug for 258 of them, across 13 drugs with 11 or more claims each, at $11,699 in total drug cost. In 2023, CMS named 22 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chang for performance year 2024, reported through an alternative payment model (APM). Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chang as offering telehealth.

Dmand AI links 18 papers to Dr. Chang, published from 2011 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Graft Rejection and Diabetic Nephropathies. Dr. Chang has published most often in Clin Transplant. Dr. Chang's most frequent co-authors are Sumit Mohan, MD, Syed Ali Husain, MD and Russell J. Crew, MD.

CMS Open Payments shows 8 general payments to Dr. Chang from 1 drug or device company from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $330.

Dr. Chang graduated from Goethe Univ Frankfurt- Fac Med in 2001.

Dr. Chang is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.